Sohn Catherine A. (0001555132)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Maze Therapeutics, Inc. 0001842295 2025-01-30 director PHARMATHENE, INC Current Name:Altimmune, Inc. 0001326190 2023-03-23 director Axcella Health Inc. 0001633070 2019-08-21 director Rubius Therapeutics, Inc. 0001709401 2018-07-17 director Jazz Pharmaceuticals plc 0001232524 2015-08-07 director Neuralstem, Inc. Current Name:PALISADE BIO, INC. 0001357459 2014-01-13 director LIFECORE BIOMEDICAL, INC. \DE\ 0001005286 2012-11-13 director

Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2025-03-17		Altimmune, Inc.	4	P-Purchase	--D	1000.0000	1000.0000	1	0001326190	Common Stock, par value $0.0001
A	2025-02-06		Altimmune, Inc.	4	A-Award	--D	18600.0000	18600.0000	1	0001326190	Stock Options (option to buy)
A	2024-09-26		Altimmune, Inc.	4	A-Award	--D	34900.0000	34900.0000	1	0001326190	Stock Options (option to buy)
A	2023-09-28		Altimmune, Inc.	4	A-Award	--D	26100.0000	26100.0000	1	0001326190	Stock Options (option to buy)
D	2023-08-14		Jazz Pharmaceuticals plc	4	S-Sale	--D	1241.0000	14868.0000	2	0001232524	Ordinary Shares
A	2023-08-11		Jazz Pharmaceuticals plc	4	A-Award	--D	3075.0000	16109.0000	1	0001232524	Ordinary Shares
A	2023-03-23		Altimmune, Inc.	4	A-Award	--D	47000.0000	47000.0000	1	0001326190	Stock Options (option to buy)
D	2022-08-08		Jazz Pharmaceuticals plc	4	S-Sale	--D	1089.0000	13034.0000	2	0001232524	Ordinary Shares
A	2022-08-05		Jazz Pharmaceuticals plc	4	A-Award	--D	2561.0000	14123.0000	1	0001232524	Ordinary Shares
A	2022-06-04		LANDEC CORP \CA\	4	A-Award	--D	7059.0000	54069.0000	1	0001005286	Common Stock
D	2022-06-04		LANDEC CORP \CA\	4	M-Exempt	--D	7059.0000	0.0000	2	0001005286	Restricted Stock Unit
A	2022-05-31		LANDEC CORP \CA\	4	A-Award	--D	9474.0000	9474.0000	1	0001005286	Restricted Stock Unit
A	2022-05-19		Axcella Health Inc.	4	A-Award	--D	20000.0000	20000.0000	1	0001633070	Stock Option (Right to Buy)
A	2022-05-12		Rubius Therapeutics, Inc.	4	A-Award	--D	25000.0000	25000.0000	1	0001709401	Stock Option (Right to Buy)
D	2021-08-06		Jazz Pharmaceuticals plc	4	S-Sale	--D	1306.0000	11562.0000	1	0001232524	Ordinary Shares
A	2021-07-29		Jazz Pharmaceuticals plc	4	A-Award	--D	2246.0000	12868.0000	1	0001232524	Ordinary Shares
A	2021-06-04		LANDEC CORP \CA\	4	A-Award	--D	7059.0000	7059.0000	1	0001005286	Restricted Stock Unit
A	2021-06-01		LANDEC CORP \CA\	4	A-Award	--D	8303.0000	47010.0000	1	0001005286	Common Stock
D	2021-06-01		LANDEC CORP \CA\	4	M-Exempt	--D	8303.0000	0.0000	2	0001005286	Restricted Stock Unit
A	2021-05-20		Axcella Health Inc.	4	A-Award	--D	20000.0000	20000.0000	1	0001633070	Stock Option (Right to Buy)
A	2021-05-12		Rubius Therapeutics, Inc.	4	A-Award	--D	25000.0000	25000.0000	1	0001709401	Stock Option (Right to Buy)
A	2020-11-04		Jazz Pharmaceuticals plc	4	M-Exempt	--D	4500.0000	15122.0000	1	0001232524	Ordinary Shares
D	2020-11-04		Jazz Pharmaceuticals plc	4	S-Sale	--D	4500.0000	10622.0000	2	0001232524	Ordinary Shares
A	2020-11-04		Jazz Pharmaceuticals plc	4	M-Exempt	--D	8000.0000	18622.0000	3	0001232524	Ordinary Shares
D	2020-11-04		Jazz Pharmaceuticals plc	4	S-Sale	--D	8000.0000	10622.0000	4	0001232524	Ordinary Shares
D	2020-11-04		Jazz Pharmaceuticals plc	4	M-Exempt	--D	8000.0000	0.0000	5	0001232524	Non-Qualified Stock Option (right to buy)
D	2020-11-04		Jazz Pharmaceuticals plc	4	M-Exempt	--D	4500.0000	0.0000	6	0001232524	Non-Qualified Stock Option (right to buy)
A	2020-10-15		LANDEC CORP \CA\	4	A-Award	--D	2200.0000	38707.0000	1	0001005286	Common Stock
D	2020-10-15		LANDEC CORP \CA\	4	M-Exempt	--D	2200.0000	0.0000	2	0001005286	Restricted Stock Unit
D	2020-08-07		Jazz Pharmaceuticals plc	4	S-Sale	--D	931.0000	10622.0000	2	0001232524	Ordinary Shares
A	2020-08-06		Jazz Pharmaceuticals plc	4	A-Award	--D	2705.0000	11553.0000	1	0001232524	Ordinary Shares
A	2020-08-06		Jazz Pharmaceuticals plc	4	A-Award	--D	6765.0000	6765.0000	3	0001232524	Non-Qualified Stock Option (right to buy)
A	2020-06-01		LANDEC CORP \CA\	4	A-Award	--D	8303.0000	8303.0000	1	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2020-05-28		LANDEC CORP \CA\	4	A-Award	--D	6000.0000	36507.0000	1	0001005286	Common Stock
D	2020-05-28		LANDEC CORP \CA\	4	M-Exempt	--D	6000.0000	0.0000	2	0001005286	Restricted Stock Unit
A	2020-05-21		Rubius Therapeutics, Inc.	4	A-Award	--D	25000.0000	25000.0000	1	0001709401	Stock Option (Right to Buy)
A	2020-05-20		Axcella Health Inc.	4	A-Award	--D	11000.0000	11000.0000	1	0001633070	Stock Option (Right to Buy)
A	2020-01-17		Axcella Health Inc.	4	P-Purchase	--D	1000.0000	1000.0000	1	0001633070	Common Stock
A	2019-10-15		LANDEC CORP \CA\	4	A-Award	--D	2200.0000	2200.0000	1	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2019-10-04		LANDEC CORP \CA\	4	M-Exempt	--D	10000.0000	39331.0000	1	0001005286	Common Stock
D	2019-10-04		LANDEC CORP \CA\	4	F-InKind	--D	8824.0000	30507.0000	2	0001005286	Common Stock
D	2019-10-04		LANDEC CORP \CA\	4	M-Exempt	--D	10000.0000	0.0000	3	0001005286	Common Stock
A	2019-08-21		Axcella Health Inc.	4	A-Award	--D	22000.0000	22000.0000	1	0001633070	Stock Option (Right to Buy)
D	2019-08-09		Jazz Pharmaceuticals plc	4	S-Sale	--D	726.0000	8848.0000	2	0001232524	Ordinary Shares
A	2019-08-08		Jazz Pharmaceuticals plc	4	A-Award	--D	1920.0000	9574.0000	1	0001232524	Ordinary Shares
A	2019-08-08		Jazz Pharmaceuticals plc	4	A-Award	--D	4805.0000	4805.0000	3	0001232524	Non-Qualified Stock Option (right to buy)
A	2019-05-30		LANDEC CORP \CA\	4	M-Exempt	--D	4240.0000	29331.0000	1	0001005286	Common Stock
D	2019-05-30		LANDEC CORP \CA\	4	M-Exempt	--D	4240.0000	0.0000	2	0001005286	Restricted Stock Unit
A	2019-05-28		LANDEC CORP \CA\	4	A-Award	--D	6000.0000	6000.0000	3	0001005286	Right to Buy Restricted Stock Units (RSU)
A	2019-05-23		Rubius Therapeutics, Inc.	4	A-Award	--D	25000.0000	25000.0000	1	0001709401	Stock Option (Right to Buy)
A	2019-01-10		LANDEC CORP \CA\	4	P-Purchase	--D	1000.0000	25091.0000	1	0001005286	Common Stock
D	2018-08-10		Jazz Pharmaceuticals plc	4	S-Sale	--D	660.0000	7654.0000	2	0001232524	Ordinary Shares
A	2018-08-09		Jazz Pharmaceuticals plc	4	A-Award	--D	1495.0000	8314.0000	1	0001232524	Ordinary Shares
A	2018-08-09		Jazz Pharmaceuticals plc	4	A-Award	--D	3735.0000	3735.0000	3	0001232524	Non-Qualified Stock Option (right to buy)
A	2018-07-20		Rubius Therapeutics, Inc.	4	P-Purchase	--D	2500.0000	2500.0000	1	0001709401	Common Stock
A	2018-07-17		Rubius Therapeutics, Inc.	4	A-Award	--D	25000.0000	25000.0000	1	0001709401	Stock Option (Right to Buy)
A	2018-05-30		LANDEC CORP \CA\	4	M-Exempt	--D	4240.0000	4240.0000	1	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2018-05-23		LANDEC CORP \CA\	4	M-Exempt	--D	4286.0000	24091.0000	1	0001005286	Common Stock
D	2018-05-23		LANDEC CORP \CA\	4	M-Exempt	--D	4286.0000	0.0000	2	0001005286	Restricted Stock Unit
D	2017-08-11		Jazz Pharmaceuticals plc	4	S-Sale	--D	659.0000	6822.0000	2	0001232524	Ordinary Shares
D	2017-08-11		Jazz Pharmaceuticals plc	4	S-Sale	--D	3.0000	6819.0000	3	0001232524	Ordinary Shares
A	2017-08-10		Jazz Pharmaceuticals plc	4	A-Award	--D	1365.0000	7481.0000	1	0001232524	Ordinary Shares
A	2017-08-10		Jazz Pharmaceuticals plc	4	A-Award	--D	3415.0000	3415.0000	4	0001232524	Non-Qualified Stock Option (right to buy)
A	2017-06-01		LANDEC CORP \CA\	4	M-Exempt	--D	4286.0000	4286.0000	1	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2017-05-25		LANDEC CORP \CA\	4	M-Exempt	--D	5282.0000	19805.0000	1	0001005286	Common Stock
D	2017-05-25		LANDEC CORP \CA\	4	M-Exempt	--D	5282.0000	0.0000	2	0001005286	Restricted Stock Unit
D	2016-08-15		Jazz Pharmaceuticals plc	4	S-Sale	--D	633.0000	6116.0000	1	0001232524	Ordinary Shares
A	2016-08-11		Jazz Pharmaceuticals plc	4	A-Award	--D	1365.0000	6749.0000	1	0001232524	Ordinary Shares
A	2016-08-11		Jazz Pharmaceuticals plc	4	A-Award	--D	3415.0000	3415.0000	2	0001232524	Non-Qualified Stock Option (right to buy)
A	2016-05-28		LANDEC CORP \CA\	4	M-Exempt	--D	3475.0000	14523.0000	1	0001005286	Common Stock
D	2016-05-28		LANDEC CORP \CA\	4	M-Exempt	--D	3475.0000	0.0000	2	0001005286	Restricted Stock Unit
A	2016-05-26		LANDEC CORP \CA\	4	M-Exempt	--D	5222.0000	5222.0000	3	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2016-05-25		LANDEC CORP \CA\	4/A	M-Exempt	--D	5282.0000	5282.0000	1	0001005286	Right to Buy Restricted Stock Unit (RSU)
A	2015-11-23		LANDEC CORP \CA\	4	M-Exempt	--D	3333.0000	11048.0000	1	0001005286	Common Stock
D	2015-11-23		LANDEC CORP \CA\	4	M-Exempt	--D	3333.0000	0.0000	2	0001005286	Restricted Stock Unit
D	2015-08-11		Jazz Pharmaceuticals plc	4	S-Sale	--D	644.0000	5394.0000	4	0001232524	Ordinary Shares
D	2015-08-11		Jazz Pharmaceuticals plc	4	S-Sale	--D	10.0000	5384.0000	5	0001232524	Ordinary Shares
D	2015-08-10		Jazz Pharmaceuticals plc	4	S-Sale	--D	797.0000	6042.0000	2	0001232524	Ordinary Shares
D	2015-08-10		Jazz Pharmaceuticals plc	4	S-Sale	--D	4.0000	6038.0000	3	0001232524	Ordinary Shares
A	2015-08-07		Jazz Pharmaceuticals plc	4	A-Award	--D	1310.0000	6839.0000	1	0001232524	Ordinary Shares

http://www.sec.gov/cgi-bin/own-disp

---